ESWT for Low Back Pain
CompletedNot applicableNCT07245498
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this interventional study is to compare the effects of ESWT in women and men between the age 18-65 with non radicular non specific low back pain . The main question it aims to answer is: Is intervention ESWT more effective than conventional physical therapy agents. Patients were divided into 2 groups; Group 1 ESWT+conventional physical therapy and group 2: sham ESWT+conventional physical therapy. Study follow up time before treatment, 0 week after treatment, and 1 month after treatment.
Study details
- Official title
- Efficacy of Extracorporeal Shock Wave Therapy in Chronic Non-radicular Low Back Pain
- Conditions
- Low Back Pain
- Physical Therapy
- Extracorporeal Shock Wave Therapy
- Interventions
- Other: extracorporeal shock wave therapy
- Sponsor
- Ankara City Hospital Bilkent
- Start date
- 2024-09-01
- Primary completion
- 2025-06-01
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Male and female patients between the ages of 18 and 65 who have had low back pain for at least three months and have been diagnosed with chronic low back pain. * Patients who consent to participate in the study according to the informed consent form will be included in the study. Exclusion Criteria: * Diagnosis of spondylolisthesis, spondylolysis, spinal tumors, intervertebral disc infections, severe osteoporosis, or lumbar vertebral fractures and patients with a history of prior spine surgery, * Currently using anti-inflammatory drugs or analgesics in last four weeks, * Local skin infection or damage at the treatment site, * Inflammatory rheumatic diseases, * Pregnancy * Concomitant mental diseases.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07245498